Medicare Reveals 44% Lower Prices For 15 Drugs In 2nd Round Of Negotiations
Medicare beneficiaries spent $1.7 billion out of pocket on the 15 drugs. The negotiated price reductions may save beneficiaries $685 million in out-of-pocket costs.
(Forbes, 2025-12-01T12:47:53Z)